Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00458991 · ClinicalTrials.gov registry record
rhGH Therapy on Hepatic Drug Metabolism
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 9
- Enrollment target
NCT00458991: Completed study, sponsored by University of Louisville.
NCT00458991 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00458991 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The purpose of the study is to understand the effect of rhGH therapy on hepatic drug metabolism in children with idiopathic growth hormone deficiency.
Interventions
- DRUG Dextromethorphan and Caffeine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2001-06 |
| Est. Completion | 2008-09 |
What the finished NCT00458991 record still lists
NCT00458991 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dextromethorphan and Caffeine is the first listed.
NCT00458991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00458991 about?
NCT00458991 is a clinical study titled "rhGH Therapy on Hepatic Drug Metabolism". The purpose of the study is to understand the effect of rhGH therapy on hepatic drug metabolism in children with idiopathic growth hormone deficiency.
What is the current status of trial NCT00458991?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2001-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00458991?
The interventions under investigation include: Dextromethorphan and Caffeine (DRUG).
Who is sponsoring clinical trial NCT00458991?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia